Advertisement

Topics

ImpediMed Company Profile

19:18 EST 18th February 2019 | BioPortfolio

Lymphedema is a condition that can cause significant swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for draining excess fluid from the body and is a key component of the immune system, is damaged or altered. In breast cancer patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that 6 percent to 40 percent of patients with breast cancer develop lymphedema, and that it often occurs within the first two years after surgery. For some cancer survivors and others at risk, a low level lymphedema can occur 10 years to 15 years following the initial primary treatment and develop into a condition that has a serious impact on overall health and quality of life. For more information about lymphedema, visit http://www.nci.nih.gov/cancerinfo/pdq/supportivecare/lymphedema/patient/.


News Articles [12 Associated News Articles listed on BioPortfolio]

ImpediMed Announces First Patient Enrolled at Scripps Memorial Hospital

ImpediMed (ASX:IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), announces that th...

ImpediMed Highlights Publication of Recommendations in New England Journal of Medicine: Supports Use of Bioimpedence and L-Dex Measurement for Lymphedema Assessment

International authority on lymphedema, Stanley G. Rockson, M.D., calls for use of Bioimpedance Spectroscopy as protocol in surveillance and assessment of cancer survi...

ImpediMed’s SOZO® Digital Health Platform Voted Among Top Five Finalists for Southern California ABBY Awards

Richard Carreon, managing director and CEO, to present at 19th Innovations in Healthcare Awards, Dec. 5, 2018, Long Beach Airport Marriott Hotel ImpediMed ...

ImpediMed Announces First Patient Enrolled at Scripps Memorial Hospital in 200-Patient Heart Failure Trial

ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance s...

Third-Party Advocacy of ImpediMed SOZO: A New Standard of Lymphedema Care for Primary Care Physicians, Health Plans and Payers

ImpediMed Limited (ASX:IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance sp...

Early Surveillance with L-Dex® Reduces Incidence, Severity & Cost of Breast Cancer-Related Lymphedema, ImpediMed Reports Publication in American Cancer Society Journal

ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance s...

ImpediMed’s SOZO® Digital Health Platform Captures First Place in 19th Innovations in Healthcare™ ABBY Award

Richard Carreon, managing director and CEO, accepts prestigious honor ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively mea...

MD Anderson Study Uses ImpediMed L-Dex Bioimpedance Spectroscopy to Assess Correlation with Limb Volume, Lymphatic Function in Lymphedema, Recommends L-Dex

Study concludes L-Dex correlates most closely with all measures and is the recommended metric when using BIS Publication of a new study to assess the validity of L-Dex ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Assessment of Unilateral Lymphoedema of the Leg

To demonstrate that ImpediMed L-Dex U400 can be used to assess unilateral Lymphoedema of the leg using the same principles for arms.

Bioimpedance Spectroscopy Compared to CardioMEMS™

Comparison of changes in diastolic pulmonary artery pressure as measured by CardioMEMS™ to impedance parameters as measured by ImpediMed's BIS technology.

Companies [2 Associated Companies listed on BioPortfolio]

ImpediMed Limited

ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and mon...

ImpediMed

Lymphedema is a condition that can cause significant swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is respo...

More Information about "ImpediMed" on BioPortfolio

We have published hundreds of ImpediMed news stories on BioPortfolio along with dozens of ImpediMed Clinical Trials and PubMed Articles about ImpediMed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ImpediMed Companies in our database. You can also find out about relevant ImpediMed Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...


Corporate Database Quicklinks



Searches Linking to this Company Record